Skip to content

Treating bronchial asthma with crude herb moxibustion: the randomized controlled clinical trials of optimizing drug prescriptions and acupoints combinations

Optimization of drug prescriptions and acupoints combinations by treating allergic rhinitis with cru

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-14005381
Enrollment
Unknown
Registered
2014-10-22
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial asthma

Interventions

Crude herb moxibustion group 1 :Raw white mustard ointment, Fei shu, Feng men, Ding chuan
Crude herb moxibustion group 2:Raw white mustard ointment, Tian tu, Da zhui, Gao huang, Shen shu
Crude herb moxibustion group 3:Cooked white mustard ointment, Fei shu, Feng men, Ding chuan
Crude herb moxibustion group 3 :Cooked white mustard ointment, Fei shu, Feng men, Ding chuan

Sponsors

Xinjiang Autonomous Region Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) conform to the diagnostic criteria of traditional Chinese medicine and asthma control test table (ACT) diagnostic criteria, western medicine diagnosis of bronchial asthma, TCM syndrome differentiation for asthma (lung qi deficiency type); (2) more than 4 weeks did not continue with theophylline or other allergy drugs; (3) comply with the severe asthma and asthma control test table (ACT) score less than 25 points; Nearly four weeks such as wheezing, cough, chest tightness bronchial asthma symptoms; (4) aged 18-65 years; (5) have signed informed consent form, provide detailed contact way, no short migration, is willing to cooperate with the visitor.

Exclusion criteria

Exclusion criteria: (1) This research is known or suspected drug allergy or have contraindication; (2) pregnancy, breast-feeding, or plan to pregnant women in the study; (3) known to have any serious illness (such as severe heart, liver, brain, blood, endocrine system disease, lung disease, etc.) other than the asthma; (4) cannot receive treatment by the regulation, unable to judge the curative effect and safety judgment; (5) asthma control test table score 25 points or more.

Design outcomes

Primary

MeasureTime frame
eosinophil cationic promtein;asthma control test;diagnostic criteria of traditional Chinese medicine;

Countries

China

Contacts

Public ContactLiu Zhiyan
343751747@qq.com+86 13899887918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026